Lack of access to affordable health products — including vaccines, drugs, contraceptives, and diagnostic tools — contributes to millions of preventable deaths each year around the globe. Not only are these products too expensive for widespread use in developing countries, but they are often impractical to store, transport, and use in communities with limited healthcare infrastructure and few trained healthcare providers.
Given its growing health R&D and manufacturing capabilities, China is uniquely positioned to help improve the quality and lower the cost of vaccines, drugs, contraceptives, and other health products for use in developing countries, particularly those in Sub-Saharan Africa.
We work with the Chinese government, the private sector, and global health partners to identify, develop and deliver high-quality, low-cost health products such as Japanese Encephalitis vaccines, polio vaccines, HPV vaccines to prevent cervical cancer, artemisinin combination therapies for malaria, long-term contraceptive implants, vaccine cold chain devices, etc. that developing countries are seeking in order to address endemic diseases and other urgent health needs.